Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21703540rdf:typepubmed:Citationlld:pubmed
pubmed-article:21703540lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:21703540lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:21703540lifeskim:mentionsumls-concept:C1155266lld:lifeskim
pubmed-article:21703540lifeskim:mentionsumls-concept:C1826442lld:lifeskim
pubmed-article:21703540lifeskim:mentionsumls-concept:C0086982lld:lifeskim
pubmed-article:21703540lifeskim:mentionsumls-concept:C0599946lld:lifeskim
pubmed-article:21703540pubmed:issue6lld:pubmed
pubmed-article:21703540pubmed:dateCreated2011-6-27lld:pubmed
pubmed-article:21703540pubmed:abstractTextThe nucleotide-binding domain and leucine-rich-repeat-containing (NLR) proteins regulate innate immunity. Although the positive regulatory impact of NLRs is clear, their inhibitory roles are not well defined. We showed that Nlrx1(-/-) mice exhibited increased expression of antiviral signaling molecules IFN-?, STAT2, OAS1, and IL-6 after influenza virus infection. Consistent with increased inflammation, Nlrx1(-/-) mice exhibited marked morbidity and histopathology. Infection of these mice with an influenza strain that carries a mutated NS-1 protein, which normally prevents IFN induction by interaction with RNA and the intracellular RNA sensor RIG-I, further exacerbated IL-6 and type I IFN signaling. NLRX1 also weakened cytokine responses to the 2009 H1N1 pandemic influenza virus in human cells. Mechanistically, Nlrx1 deletion led to constitutive interaction of MAVS and RIG-I. Additionally, an inhibitory function is identified for NLRX1 during LPS activation of macrophages where the MAVS-RIG-I pathway was not involved. NLRX1 interacts with TRAF6 and inhibits NF-?B activation. Thus, NLRX1 functions as a checkpoint of overzealous inflammation.lld:pubmed
pubmed-article:21703540pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:languageenglld:pubmed
pubmed-article:21703540pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:citationSubsetIMlld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21703540pubmed:statusMEDLINElld:pubmed
pubmed-article:21703540pubmed:monthJunlld:pubmed
pubmed-article:21703540pubmed:issn1097-4180lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:YuLeiLlld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:PicklesRaymon...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:SambharaSurya...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:GrisDenisDlld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:DavisBeckley...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:RanjanPriyaPlld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:RoneyKelly...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:TingJenny P...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:AllenIrving...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:MooreChris...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:ZimmermannAlb...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:SchneiderMoni...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:ScullMargaret...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:MonroeKathryn...lld:pubmed
pubmed-article:21703540pubmed:authorpubmed-author:BowzardJohn...lld:pubmed
pubmed-article:21703540pubmed:copyrightInfoCopyright © 2011 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:21703540pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21703540pubmed:day24lld:pubmed
pubmed-article:21703540pubmed:volume34lld:pubmed
pubmed-article:21703540pubmed:ownerNLMlld:pubmed
pubmed-article:21703540pubmed:authorsCompleteYlld:pubmed
pubmed-article:21703540pubmed:pagination854-65lld:pubmed
pubmed-article:21703540pubmed:dateRevised2011-9-6lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:meshHeadingpubmed-meshheading:21703540...lld:pubmed
pubmed-article:21703540pubmed:year2011lld:pubmed
pubmed-article:21703540pubmed:articleTitleNLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-?B signaling pathways.lld:pubmed
pubmed-article:21703540pubmed:affiliationThe Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.lld:pubmed
pubmed-article:21703540pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21703540pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:270151entrezgene:pubmedpubmed-article:21703540lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21703540lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21703540lld:pubmed